DBVT
DBV Technologies S.A.
+0.74 (+6.23%)12.53USD103K成交股數–市值–本益比(近四季)–股價營收比-53.3%營收年增(近四季)2026-10-28下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 1K · 1 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 1K |
| 近 180 天 淨額 | −1K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 | 07-31 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 464 | 2.70 | 1K | 145K | SEC |
| 2026-01-29 | 02-02 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 534 | 4.86 | 3K | 145K | SEC |
| 2025-12-18 | 12-19 | EPIC Bpifrance | Other | S 公開市場賣出 | 1.3M | 4.19 | 5.4M | 7.3M | SEC |
| 2025-12-18 | 12-19 | CAISSE DES DEPOTS ET CONSIGNATIONS | Other | S 公開市場賣出 | 1.3M | 4.19 | 5.4M | 7.3M | SEC |
| 2025-12-18 | 12-19 | Bpifrance Participations SA | Other | S 公開市場賣出 | 1.3M | 4.19 | 5.4M | 7.3M | SEC |
| 2025-12-18 | 12-19 | Bpifrance SA | Other | S 公開市場賣出 | 1.3M | 4.19 | 5.4M | 7.3M | SEC |
| 2025-12-18 | 12-19 | Bpifrance Investissement S.A.S. | Other | S 公開市場賣出 | 1.3M | 4.19 | 5.4M | 7.3M | SEC |
| 2025-12-17 | 12-19 | CAISSE DES DEPOTS ET CONSIGNATIONS | Other | S 公開市場賣出 | 40.0K | 5.28 | 211K | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance SA | Other | S 公開市場賣出 | 2.0M | 4.84 | 9.9M | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance SA | Other | S 公開市場賣出 | 40.0K | 5.28 | 211K | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance Participations SA | Other | S 公開市場賣出 | 40.0K | 5.28 | 211K | 8.6M | SEC |
| 2025-12-17 | 12-19 | EPIC Bpifrance | Other | S 公開市場賣出 | 2.0M | 4.84 | 9.9M | 8.6M | SEC |
| 2025-12-17 | 12-19 | EPIC Bpifrance | Other | S 公開市場賣出 | 40.0K | 5.28 | 211K | 8.6M | SEC |
| 2025-12-17 | 12-19 | CAISSE DES DEPOTS ET CONSIGNATIONS | Other | S 公開市場賣出 | 2.0M | 4.84 | 9.9M | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance Investissement S.A.S. | Other | S 公開市場賣出 | 2.0M | 4.84 | 9.9M | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance Investissement S.A.S. | Other | S 公開市場賣出 | 40.0K | 5.28 | 211K | 8.6M | SEC |
| 2025-12-17 | 12-19 | Bpifrance Participations SA | Other | S 公開市場賣出 | 2.0M | 4.84 | 9.9M | 8.6M | SEC |
| 2025-11-21 | 11-25 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 1.6K | 2.77 | 4K | 102K | SEC |
| 2025-11-21 | 11-25 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 44.0K | – | – | 146K | SEC |
| 2025-11-21 | 11-24 | Boucinha Virginie | Chief Financial Officer | A 獲配股票 | 32.0K | – | – | 70.0K | SEC |
| 2025-11-21 | 11-24 | Trapp Kevin Michael | Chief Commercial Officer | A 獲配股票 | 55.0K | – | – | 55.0K | SEC |
| 2025-11-20 | 11-25 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 6.5K | 2.88 | 19K | 103K | SEC |
| 2025-07-29 | 07-31 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 464 | 2.22 | 1K | 110K | SEC |
| 2025-05-22 | 05-27 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 397 | 1.84 | 730.48 | 110K | SEC |
| 2025-01-30 | 01-31 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 600 | 0.85 | 510.00 | 111K | SEC |
| 2024-11-25 | 11-27 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 565 | 0.57 | 322.05 | 111K | SEC |
| 2024-11-22 | 11-27 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 342 | 0.53 | 181.26 | 112K | SEC |
| 2024-11-21 | 11-25 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 2.4K | 0.54 | 1K | 112K | SEC |
| 2024-11-21 | 11-25 | Boucinha Virginie | Chief Financial Officer | A 獲配股票 | 19.0K | – | – | 38.0K | SEC |
| 2024-11-21 | 11-25 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 35.0K | – | – | 114K | SEC |
| 2024-07-29 | 07-31 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 1.8K | 0.98 | 2K | 79.4K | SEC |
| 2024-05-24 | 05-29 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 660 | 1.36 | 897.60 | 81.2K | SEC |
| 2024-05-22 | 05-29 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 382 | 1.38 | 527.16 | 81.8K | SEC |
| 2024-03-08 | 03-11 | Tasse Daniel | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 17.1K | 0.83 | 14K | 17.1K | SEC |
| 2024-02-06 | 02-08 | Ndu Adora | Director | P 公開市場買進 | 1.8K | 0.89 | 2K | 1.8K | SEC |
| 2023-11-22 | 12-19 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 2.2K | 1.74 | 4K | 82.2K | SEC |
| 2023-11-20 | 11-22 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 35.0K | – | – | 84.4K | SEC |
| 2023-11-20 | 11-22 | Boucinha Virginie | Chief Financial Officer | A 獲配股票 | 19.0K | – | – | 19.0K | SEC |
| 2023-08-25 | 08-28 | MORRIS TIMOTHY E | Director | P 公開市場買進 | 12.0K | 1.52 | 18K | 12.0K | SEC |
| 2023-08-01 | 08-03 | SOLAND DANIEL B | Director | P 公開市場買進 | 15.0K | 1.62 | 24K | 20.0K | SEC |
| 2023-05-24 | 08-14 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 469 | 3.54 | 2K | 49.4K | SEC |
| 2022-11-24 | 08-14 | Mohideen Pharis | Chief Medical Officer | S 公開市場賣出 | 1.8K | 2.88 | 5K | 49.9K | SEC |
| 2022-11-21 | 08-14 | Robitaille Sebastien | Chief Financial Officer | A 獲配股票 | 8.0K | – | – | 36.5K | SEC |
| 2022-11-21 | 08-14 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 17.5K | – | – | 51.7K | SEC |
| 2022-07-29 | 08-14 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 10.0K | – | – | 34.2K | SEC |
| 2022-06-13 | 06-13 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2022-06-13 | 06-13 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2022-06-13 | 06-13 | 667, L.P. | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | 667, L.P. | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2022-06-13 | 06-13 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2022-06-13 | 06-13 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | BAKER JULIAN | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | BAKER JULIAN | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2022-06-13 | 06-13 | BAKER FELIX | Director,TenPercentOwner | A 獲配股票 | 1.3M | – | – | 1.6M | SEC |
| 2022-06-13 | 06-13 | BAKER FELIX | Director,TenPercentOwner | A 獲配股票 | 10.6M | – | – | 14.6M | SEC |
| 2021-11-22 | 11-24 | Robitaille Sebastien | Chief Financial Officer | A 獲配股票 | 5.0K | – | – | 28.5K | SEC |
| 2021-11-22 | 11-24 | Mohideen Pharis | Chief Medical Officer | A 獲配股票 | 8.7K | – | – | 24.2K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | 3.7M | 60.1M | −1.5M (-30%) | 減碼 |
| Siren, L.L.C. | 1.9M | 30.5M | 不變 | 持平 |
| Vivo Capital, LLC | 1.8M | 30.3M | −823K (-31%) | 減碼 |
| PERCEPTIVE ADVISORS LLC | 1.7M | 27.1M | +689K (+71%) | 加碼 |
| BAKER BROS. ADVISORS LP | 1.5M | 24.0M | 不變 | 持平 |
| Artisan Partners Limited Partnership | 1.4M | 22.5M | −847K (-38%) | 減碼 |
| UBS Group AG | 1.3M | 21.5M | +1.2M (+1551%) | 加碼 |
| MORGAN STANLEY | 955K | 15.7M | +809K (+554%) | 加碼 |
| Logos Global Management LP | 915K | 15.0M | 新進 | 新進 |
| Patient Square Capital LP | 909K | 14.9M | +216K (+31%) | 加碼 |
| Octagon Capital Advisors LP | 574K | 9.4M | 不變 | 持平 |
| ADAR1 Capital Management, LLC | 528K | 8.7M | −485K (-48%) | 減碼 |
| Redmile Group, LLC | 410K | 6.7M | −80.9K (-16%) | 減碼 |
| AMERIPRISE FINANCIAL INC | 378K | 6.2M | +147K (+64%) | 加碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 268K | 4.4M | −51.2K (-16%) | 減碼 |
| Elmind Capital, LP | 265K | 4.3M | 不變 | 持平 |
| JANE STREET GROUP, LLC | 224K | 3.7M | +213K (+1884%) | 加碼 |
| Ishara Investments LP | 185K | 3.0M | +82.0K (+80%) | 加碼 |
| Yiheng Capital Management, L.P. | 170K | 2.8M | 不變 | 持平 |
| BOOTHBAY FUND MANAGEMENT, LLC | 163K | 2.7M | 不變 | 持平 |
| GREAT POINT PARTNERS LLC | 157K | 2.6M | 新進 | 新進 |
| NEW YORK STATE COMMON RETIREMENT FUND | 119K | 2.0M | −48.8K (-29%) | 減碼 |
| ENVESTNET ASSET MANAGEMENT INC | 114K | 1.9M | +18.1K (+19%) | 加碼 |
| Ikarian Capital, LLC | 525K | 1.7M | 不變 | 持平 |
| XTX Topco Ltd | 91.2K | 1.5M | +49.1K (+117%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 78 +7 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 17 / 10 / 17 / 24 |
| 機構合計持股 · 佔流通股 | 21.5M |
| 合計季末市值 | 337M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.6M |
|---|---|
| 與上期比 | -3.0% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 163K |
| 回補天數 | 9.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.6M | -3.0% | – | 163K | 9.7 |
| 2026-08-14 | 1.6M | -11.7% | – | 411K | 4.0 |
| 2026-07-31 | 1.8M | +25.7% | – | 370K | 5.0 |
| 2026-07-15 | 1.5M | +13.2% | – | 188K | 7.8 |
| 2026-06-30 | 1.3M | -8.7% | – | 352K | 3.7 |
| 2026-06-15 | 1.4M | -14.6% | – | 259K | 5.5 |
| 2026-05-29 | 1.7M | -7.5% | – | 282K | 5.9 |
| 2026-05-15 | 1.8M | -0.8% | – | 179K | 10.1 |
| 2026-04-30 | 1.8M | +14.3% | – | 200K | 9.1 |
| 2026-04-15 | 1.6M | -6.0% | – | 246K | 6.4 |
| 2026-03-31 | 1.7M | +12.9% | – | 229K | 7.4 |
| 2026-03-13 | 1.5M | +12.8% | – | 335K | 4.5 |
| 2026-02-27 | 1.3M | +7.8% | – | 131K | 10.1 |
| 2026-02-13 | 1.2M | -2.0% | – | 348K | 3.5 |
| 2026-01-30 | 1.3M | +0.5% | – | 581K | 2.2 |
| 2026-01-15 | 1.2M | +40.1% | – | 364K | 3.4 |
| 2025-12-31 | 891K | +440.8% | – | 774K | 1.2 |
| 2025-12-15 | 165K | +411.4% | – | 671K | 1.0 |
| 2025-11-28 | 32.2K | -1.4% | – | 196K | 1.0 |
| 2025-11-14 | 32.7K | +50.6% | – | 82.0K | 1.0 |
| 2025-10-31 | 21.7K | +0.5% | – | 164K | 1.0 |
| 2025-10-15 | 21.6K | +15.5% | – | 223K | 1.0 |
| 2025-09-30 | 18.7K | +0.1% | – | 47.8K | 1.0 |
| 2025-09-15 | 18.7K | -0.6% | – | 28.9K | 1.0 |
| 2025-08-29 | 18.8K | +71.8% | – | 42.1K | 1.0 |
| 2025-08-15 | 10.9K | -6.1% | – | 28.1K | 1.0 |